A detailed history of Foyston, Gordon, & Payne Inc transactions in Sanofi stock. As of the latest transaction made, Foyston, Gordon, & Payne Inc holds 5,784 shares of SNY stock, worth $280,119. This represents 0.09% of its overall portfolio holdings.

Number of Shares
5,784
Previous 30,012 80.73%
Holding current value
$280,119
Previous $1.46 Million 77.13%
% of portfolio
0.09%
Previous 0.37%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$48.54 - $58.53 $1.18 Million - $1.42 Million
-24,228 Reduced 80.73%
5,784 $333,000
Q2 2024

Jul 30, 2024

SELL
$45.39 - $50.36 $86,422 - $95,885
-1,904 Reduced 5.97%
30,012 $1.46 Million
Q1 2024

May 07, 2024

SELL
$45.75 - $52.48 $41,769 - $47,914
-913 Reduced 2.78%
31,916 $1.55 Million
Q4 2023

Feb 07, 2024

SELL
$43.13 - $54.79 $424,140 - $538,804
-9,834 Reduced 23.05%
32,829 $1.63 Million
Q3 2023

Oct 26, 2023

BUY
$50.95 - $55.2 $157,180 - $170,292
3,085 Added 7.79%
42,663 $2.29 Million
Q2 2023

Aug 01, 2023

SELL
$50.45 - $57.18 $98,327 - $111,443
-1,949 Reduced 4.69%
39,578 $2.13 Million
Q1 2023

May 03, 2023

SELL
$45.86 - $54.45 $317,763 - $377,284
-6,929 Reduced 14.3%
41,527 $2.26 Million
Q4 2022

Feb 09, 2023

SELL
$38.86 - $48.55 $125,634 - $156,962
-3,233 Reduced 6.25%
48,456 $2.35 Million
Q3 2022

Nov 04, 2022

BUY
$37.22 - $100.5 $1.72 Million - $4.65 Million
46,225 Added 845.99%
51,689 $1.97 Million
Q2 2022

Aug 11, 2022

SELL
$48.99 - $57.46 $1.93 Million - $2.27 Million
-39,430 Reduced 87.83%
5,464 $2.08 Million
Q1 2022

Apr 27, 2022

SELL
$48.48 - $53.65 $25,064 - $27,737
-517 Reduced 1.14%
44,894 $2.31 Million
Q4 2021

Feb 11, 2022

SELL
$47.07 - $52.35 $91,786 - $102,082
-1,950 Reduced 4.12%
45,411 $2.28 Million
Q3 2021

Nov 12, 2021

SELL
$47.89 - $53.12 $46,213 - $51,260
-965 Reduced 2.0%
47,361 $2.28 Million
Q2 2021

Aug 06, 2021

BUY
$49.36 - $54.25 $284,708 - $312,914
5,768 Added 13.55%
48,326 $2.55 Million
Q1 2021

May 14, 2021

BUY
$45.46 - $50.51 $118,832 - $132,033
2,614 Added 6.54%
42,558 $2.11 Million
Q4 2020

Feb 12, 2021

SELL
$45.3 - $51.62 $379,115 - $432,007
-8,369 Reduced 17.32%
39,944 $1.94 Million
Q3 2020

Nov 12, 2020

SELL
$49.47 - $53.77 $196,148 - $213,198
-3,965 Reduced 7.58%
48,313 $2.42 Million
Q2 2020

Aug 14, 2020

SELL
$42.91 - $52.5 $163,572 - $200,130
-3,812 Reduced 6.8%
52,278 $2.67 Million
Q1 2020

May 15, 2020

SELL
$38.02 - $51.66 $155,159 - $210,824
-4,081 Reduced 6.78%
56,090 $2.45 Million
Q4 2019

Feb 14, 2020

SELL
$44.25 - $50.86 $190,983 - $219,511
-4,316 Reduced 6.69%
60,171 $3.02 Million
Q3 2019

Nov 14, 2019

BUY
$40.34 - $46.64 $53,329 - $61,658
1,322 Added 2.09%
64,487 $2.99 Million
Q2 2019

Aug 15, 2019

SELL
$40.43 - $44.3 $55,025 - $60,292
-1,361 Reduced 2.11%
63,165 $2.73 Million
Q1 2019

May 14, 2019

SELL
$40.83 - $45.43 $1.42 Million - $1.58 Million
-34,774 Reduced 35.02%
64,526 $2.86 Million
Q4 2018

Feb 08, 2019

BUY
$41.48 - $45.59 $4.12 Million - $4.53 Million
99,300 New
99,300 $4.31 Million
Q1 2018

May 14, 2018

SELL
$38.98 - $45.76 $929,672 - $1.09 Million
-23,850 Closed
0 $0
Q2 2017

Aug 14, 2017

BUY
N/A
23,850
23,850 $1.14 Million

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $121B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Foyston, Gordon, & Payne Inc Portfolio

Follow Foyston, Gordon, & Payne Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foyston, Gordon, & Payne Inc, based on Form 13F filings with the SEC.

News

Stay updated on Foyston, Gordon, & Payne Inc with notifications on news.